C-reactive protein as a predictor of adverse outcome in patients with acute coronary syndrome
Open Access
- 1 January 2012
- journal article
- research article
- Published by Medknow in Heart Views
- Vol. 13 (1), 7-12
- https://doi.org/10.4103/1995-705x.96660
Abstract
Background and Objectives: The acute-phase reactant C-reactive protein (CRP) has been shown to reflect systemic and vascular inflammation and to predict future cardiovascular events. The objective of this study was to evaluate the prognostic value of CRP in predicting cardiovascular outcome in patients presenting with acute coronary syndromes. Patients and Methods: This prospective, single-centered study was carried out by the Department of Pathology in collaboration with the Department of Cardiology, Bolan Medical College Complex Quetta, Balochistan, Pakistan from January 2009 to December 2009. We studied 963 consecutive patients presenting with chest pain to Accident and Emergency Department. Patients were divided into four groups. Group-1 comprised patients with unstable angina; group-2 included patients with acute ST elevation myocardial infarction (STEMI); group-3 comprised patients with Non-ST elevation myocardial infarction (Non-STEMI) and group-4 was the control group. All four groups were followed-up for 90 days for occurrence of cardiovascular events. Results: The CRP was elevated (>3 mg/L) among 27.6% patients in Group-1; 70.9% in group- 2; 77.9% in group-3 and 5.3% in the control group. Among cases with elevated CRP, 92.1% had a cardiac event compared to 34.3% among patients with CRP £3 mg/L (P < 0.0001). The mortality was significantly higher (P < 0.0001) in group-2 (8.9%) and group-3 (11.9%) as compared to group-1 (2.1%). There was no cardiac event or mortality in Group-4. Conclusions: Elevated CRP is a predictor of adverse outcome in patients with acute coronary syndromes and helps in identifying patients who may be at risk of cardiovascular complications.Keywords
This publication has 36 references indexed in Scilit:
- Soluble CD40LCirculation, 2003
- Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial InfarctionCirculation, 2003
- Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary SyndromesCirculation, 2002
- Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysisJournal of the American College of Cardiology, 2000
- Atherosclerosis — An Inflammatory DiseaseThe New England Journal of Medicine, 1999
- A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cellsImmunology Today, 1997
- Interleukin-8 as a sensitive marker of unstable coronary artery diseaseThe American Journal of Cardiology, 1996
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesThe New England Journal of Medicine, 1992
- Elevation of C-reactive protein in “active” coronary artery diseaseThe American Journal of Cardiology, 1990
- Circulating tumour necrosis factor‐α (cachectin) in myocardial infarctionJournal of Internal Medicine, 1989